Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
exclusivity
Pharma
Teva launches Revlimid generic, the first to do so in U.S.
Generic competition for BMS' Revlimid is finally here. On Monday, Teva said became the first to launch a Revlimid generic in the U.S.
Kevin Dunleavy
Mar 7, 2022 11:11am
Catalyst one-ups Jacobus, FDA in Firdapse exclusivity appeal
Oct 1, 2021 12:11pm
Novartis sues FDA, claiming Sanofi's Aubagio isn't really new
Mar 11, 2021 11:34am
Gilead tries—and fails—to bail out of HIV drug safety lawsuit
May 14, 2019 10:43am
Eight senators pile on to Marathon's $89K Emflaza price tag
Mar 6, 2017 10:30am
